2023
DOI: 10.1007/s12672-023-00692-5
|View full text |Cite
|
Sign up to set email alerts
|

NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway

Abstract: Objectives The NEK2 (never in mitosis gene A-related kinase 2), a serine/threonine kinase involved in chromosome instability and tumorigenesis. Hence, this study aimed to explore the molecular function of NEK2 in esophageal squamous cell carcinoma (ESCC). Methods By available transcriptome datasets (GSE53625 cohort, GSE38129 cohort, and GSE21293 cohort), we analyzed the differentially expressed genes in invading and non-invading ESCC. Subsequently,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 48 publications
(42 reference statements)
0
5
0
Order By: Relevance
“…NEK2 overexpression has been found in various human malignancies [73][74][75][76][77][78][79][80], including gastrointestinal tumors [81,82]. Aberrant NEK2 expression in cancers has been associated with tumor cell proliferation [83], migration [82], invasion [74,77], drug/radio resistance [84,85], immune response [80,86], and poor prognosis [26,75]. In our bioinformatics analyses, NEK2 is the most frequently upregulated NEK member in EAC (significantly detected in seven of the eight databases).…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…NEK2 overexpression has been found in various human malignancies [73][74][75][76][77][78][79][80], including gastrointestinal tumors [81,82]. Aberrant NEK2 expression in cancers has been associated with tumor cell proliferation [83], migration [82], invasion [74,77], drug/radio resistance [84,85], immune response [80,86], and poor prognosis [26,75]. In our bioinformatics analyses, NEK2 is the most frequently upregulated NEK member in EAC (significantly detected in seven of the eight databases).…”
Section: Discussionmentioning
confidence: 78%
“…In addition, NEK2 may also play a role in microtubule stabilization [70], B cell development and immunological response [71], and splicing [72]. NEK2 overexpression has been found in various human malignancies [73][74][75][76][77][78][79][80], including gastrointestinal tumors [81,82]. Aberrant NEK2 expression in cancers has been associated with tumor cell proliferation [83], migration [82], invasion [74,77], drug/radio resistance [84,85], immune response [80,86], and poor prognosis [26,75].…”
Section: Discussionmentioning
confidence: 99%
“…Initially, NEK2's promotion of the cell cycle was identified as a major factor contributing to its pro-tumor effects. As a result, the objective of targeting NEK2 to achieve effective anti-tumor outcomes is centered around inhibiting the progression of cancer cells through slowing down their cell cycle during mitosis and cytokinesis [29,30]. NEK2 is upregulated in cancer and has been linked to the initiation, advancement, spread, and resistance to treatment of tumors [31].…”
Section: Discussionmentioning
confidence: 99%
“…Knockdown of NEK2 inhibits activation of the Wnt1/β-catenin signaling pathway [ 49 ]. The Wnt/β-catenin pathway is the downstream pathway of NEK2, which promotes cell proliferation, migration and invasion by activating the Wnt/β-catenin pathway [ 50 ]. So, the GTSE1 , MELK , CDK1 , ECT2 , and NEK2 genes may be involved in the molecular regulation of feather follicle density.…”
Section: Discussionmentioning
confidence: 99%